RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Escalating Clopidogrel by Involving a Genetic Strategy-TIMI 56
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 15
SP 11
OP 11
DO 10.1177/155989771115004
UL http://mdc.sagepub.com/content/11/15/11.abstract
AB Results of the EscaLating ClopidogrEl by InVolving A GeneTic StratEgy — Thrombolysis In Myocardial Infarction 56 [ELEVATE TIMI 56] trial showed that tripling the maintenance dose of clopidogrel in CYP2C19*2 heterozygote patients achieved levels of platelet reactivity that were similar to the standard-dose clopidogrel in noncarriers.